Home > Cashflow Statement > GENPHARMASEC

GENPHARMASEC
Cashflow Statement

GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Cashflow Statement History

[Consolidated]

Mar2024Mar2023
Profit Before Tax₹0.25 Cr₹0.28 Cr
Adjustment ₹0.39 Cr₹0.16 Cr
Changes In working Capital ₹-3.54 Cr₹-3.77 Cr
Cash Flow after changes in Working Capital ₹-2.91 Cr₹-3.32 Cr
Cash Flow from Operating Activities ₹-2.95 Cr₹-3.06 Cr
Cash Flow from Investing Activities ₹-28 Cr₹0.36 Cr
Cash Flow from Financing Activities ₹48 Cr₹3.08 Cr
Net Cash Inflow / Outflow ₹17 Cr₹0.39 Cr
Opening Cash & Cash Equivalents ₹1.99 Cr₹1.61 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger --
Cash & Cash Equivalent of Subsidiaries under liquidations --
Translation adjustment on reserves / op cash balalces frgn subsidiaries --
Effect of Foreign Exchange Fluctuations --
Closing Cash & Cash Equivalent ₹19 Cr₹1.99 Cr

Compare Cashflow Statement of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹112.4 Cr 1% -1% -12.8% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹9,906.9 Cr 1.3% 1.4% 36.7% Stock Analytics
KIRI INDUSTRIES ₹3,243.2 Cr 7.1% 1% 73.6% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹2,038.3 Cr 0.5% -3% -8.8% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,174.2 Cr 3.1% 19.3% 54.8% Stock Analytics
BODAL CHEMICALS ₹964.9 Cr 2.6% 14% 0.8% Stock Analytics


GENPHARMASEC Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

1%

-1%

-12.8%

SENSEX

-0.9%

0.4%

1.4%


You may also like the below Video Courses